First Header Logo Second Header Logo

Connection

Steven Feldman to Dermatologic Agents

Back to Details
This is a "connection" page, showing publications Steven Feldman has written about Dermatologic Agents.
Steven Feldman
Connection Strength
49.812
Dermatologic Agents
  1. Emmerich VK, Purvis CG, Feldman SR. An overview of adapalene and benzoyl peroxide once-daily topical gel as a therapeutic option for acne. Expert Opin Pharmacother. 2021 Sep; 22(13):1661-1667.
    View in: PubMed
    Score: 0.591
  2. Bashyam AM, Cuellar-Barboza A, Masicampo EJ, Feldman SR. Framing atopic dermatitis topical medication application site discomfort as a signal of efficacy improves willingness to continue use. J Am Acad Dermatol. 2020 Dec; 83(6):1773-1775.
    View in: PubMed
    Score: 0.544
  3. Johnson MC, Hamid RN, Feldman SR. The Cash Pharmacy Model May Effectively Lower Prescription Drug Prices. J Drugs Dermatol. 2020 Apr 01; 19(4):429-430.
    View in: PubMed
    Score: 0.544
  4. Balogh EA, Bashyam AM, Ghamrawi RI, Feldman SR. Emerging systemic drugs in the treatment of plaque psoriasis. Expert Opin Emerg Drugs. 2020 06; 25(2):89-100.
    View in: PubMed
    Score: 0.544
  5. Ramachandran V, Bertus B, Bashyam AM, Feldman SR. Treating Psoriasis With Halobetasol Propionate and Tazarotene Combination: A Review of Phase II and III Clinical Trials. Ann Pharmacother. 2020 09; 54(9):872-878.
    View in: PubMed
    Score: 0.541
  6. Howell AN, Ghamrawi RI, Strowd LC, Feldman SR. Pharmacological management of atopic dermatitis in the elderly. Expert Opin Pharmacother. 2020 May; 21(7):761-771.
    View in: PubMed
    Score: 0.541
  7. Wilson BN, Balogh EA, Feldman SR. Medications in dermatology are safer and more efficient than they used to be. Expert Opin Drug Saf. 2020 Apr; 19(4):359-360.
    View in: PubMed
    Score: 0.540
  8. Bray JK, Masicampo EJ, Feldman SR. The bandwagon effect increases acne treatment willingness in teenagers. J Am Acad Dermatol. 2020 Oct; 83(4):1172-1174.
    View in: PubMed
    Score: 0.538
  9. Haidari W, Pona A, Feldman SR. Management of Residual Psoriasis in Patients on Biologic Treatment J Drugs Dermatol. 2020 Feb 02; 19(2):188-194.
    View in: PubMed
    Score: 0.538
  10. Bashyam AM, Cuellar-Barboza A, Ghamrawi RI, Feldman SR. Placebo tailoring improves patient satisfaction of treatment plans in atopic dermatitis. J Am Acad Dermatol. 2020 Sep; 83(3):944-946.
    View in: PubMed
    Score: 0.538
  11. Feldman SR, Zhang J, Martinez DJ, Lopez-Gonzalez L, Marchlewicz EH, Shrady G, Mendelsohn AM, Zhao Y. Real-world treatment patterns and healthcare costs of biologics and apremilast among patients with moderate-to-severe plaque psoriasis by metabolic condition status. J Dermatolog Treat. 2021 Mar; 32(2):203-211.
    View in: PubMed
    Score: 0.532
  12. Bray JK, Johnson MC, Masicampo EJ, Feldman SR. Optimizing presentation of expected treatment outcomes. J Am Acad Dermatol. 2020 Aug; 83(2):602-604.
    View in: PubMed
    Score: 0.519
  13. Kolli SS, Pecone D, Pona A, Cline A, Feldman SR. Topical Retinoids in Acne Vulgaris: A Systematic Review. Am J Clin Dermatol. 2019 Jun; 20(3):345-365.
    View in: PubMed
    Score: 0.514
  14. Kolli SS, Kepley AL, Cline A, Feldman SR. A safety review of recent advancements in the treatment of psoriasis: analysis of clinical trial safety data. Expert Opin Drug Saf. 2019 06; 18(6):523-536.
    View in: PubMed
    Score: 0.512
  15. Pona A, Haidari W, Kolli SS, Feldman SR. Diet and psoriasis. Dermatol Online J. 2019 Feb 15; 25(2).
    View in: PubMed
    Score: 0.503
  16. Glines KR, Stiff KM, Freeze M, Cline A, Strowd LC, Feldman SR. An update on the topical and oral therapy options for treating pediatric atopic dermatitis. Expert Opin Pharmacother. 2019 04; 20(5):621-629.
    View in: PubMed
    Score: 0.499
  17. Heath MS, Kolli SS, Dowling JR, Cline A, Feldman SR. Pharmacotherapeutic strategies for standard treatment-resistant psoriasis. Expert Opin Pharmacother. 2019 03; 20(4):443-454.
    View in: PubMed
    Score: 0.499
  18. Oussedik E, Hessel AB, Feldman SR. Automobile injury: a common familiar risk for presenting and comparing risks in dermatology. Cutis. 2018 Dec; 102(6):416-420.
    View in: PubMed
    Score: 0.496
  19. Bartos G, Cline A, Beroukhim K, Burrall BA, Feldman SR. Current biological therapies for use in HIV-positive patients with psoriasis: case report of gesulkumab used and review. Dermatol Online J. 2018 Nov 15; 24(11).
    View in: PubMed
    Score: 0.495
  20. Feaster B, Cline A, Feldman SR. Secukinumab for psoriasis in a patient with hepatitis B. Dermatol Online J. 2018 Sep 15; 24(9).
    View in: PubMed
    Score: 0.489
  21. Feldman SR, Zhao Y, Gilloteau I, Graham CN, Miles L, McBride D, Herrera V. Higher Psoriasis Skin Clearance Is Associated with Lower Annual Indirect Costs in the United States: A Post Hoc Analysis from the CLEAR Study. J Manag Care Spec Pharm. 2018 Jul; 24(7):617-622.
    View in: PubMed
    Score: 0.482
  22. Al-Dabagh A, Feldman S. Restrictions on blood donations relevant to dermatology. Dermatol Online J. 2018 Apr 15; 24(4).
    View in: PubMed
    Score: 0.475
  23. McGregor SP, Alinia H, Snyder A, Tuchayi SM, Fleischer A, Feldman SR. A Review of the Current Modalities for the Treatment of Papulopustular Rosacea. Dermatol Clin. 2018 Apr; 36(2):135-150.
    View in: PubMed
    Score: 0.465
  24. Feldman SR, Foster SA, Zhu B, Burge R, Al Sawah S, Goldblum OM. Cost Per Additional Responder Associated With Ixekizumab and Etanercept in the Treatment of Moderate-to-Severe Psoriasis. J Drugs Dermatol. 2017 12 01; 16(12):1246-1252.
    View in: PubMed
    Score: 0.463
  25. Patel NU, Grammenos A, Gowda A, Onikoyi O, Feldman SR. 4-Day evaluation of the irritation potential of topical desoximetasone 0.25% and 0.05% spray on light-exposed skin. J Dermatolog Treat. 2018 Jun; 29(4):415-417.
    View in: PubMed
    Score: 0.461
  26. Feldman SR, Lacy FA, Huang WW. The safety of treatments used in pyoderma gangrenosum. Expert Opin Drug Saf. 2018 01; 17(1):55-61.
    View in: PubMed
    Score: 0.460
  27. Alexander T, Maxim E, Cardwell LA, Chawla A, Feldman SR. Prescriptions for atopic dermatitis: oral corticosteroids remain commonplace. J Dermatolog Treat. 2018 May; 29(3):238-240.
    View in: PubMed
    Score: 0.458
  28. Oussedik E, Patel NU, Cash DR, Gupta AS, Feldman SR. Severe and acute complications of biologics in psoriasis. G Ital Dermatol Venereol. 2017 Dec; 152(6):586-596.
    View in: PubMed
    Score: 0.456
  29. Nadkarni A, Saleem MD, Feldman SR. Topical Desoximetasone 0.25% Spray and Its Vehicle Have Little Potential for Irritation or Sensitization. J Drugs Dermatol. 2017 Aug 01; 16(8):755-758.
    View in: PubMed
    Score: 0.452
  30. Patel NU, D'Ambra V, Feldman SR. Increasing Adherence with Topical Agents for Atopic Dermatitis. Am J Clin Dermatol. 2017 Jun; 18(3):323-332.
    View in: PubMed
    Score: 0.447
  31. Saleem MD, Feldman SR. Desoximetasone 0.25% spray, adrenal suppression and efficacy in extensive plaque psoriasis. J Dermatolog Treat. 2018 Feb; 29(1):36-38.
    View in: PubMed
    Score: 0.447
  32. Saleem MD, Negus D, Feldman SR. Topical 0.25% desoximetasone spray efficacy for moderate to severe plaque psoriasis: a randomized clinical trial. J Dermatolog Treat. 2018 Feb; 29(1):32-35.
    View in: PubMed
    Score: 0.447
  33. Vale SM, Hill D, Feldman SR. Pharmacoeconomic Considerations in Treating Actinic Keratosis: An Update. Pharmacoeconomics. 2017 02; 35(2):177-190.
    View in: PubMed
    Score: 0.437
  34. Vera N, Patel N, Cardwell LA, Saleem M, Feldman SR. Chemical pharmacotherapy options for managing adult acne. Expert Opin Pharmacother. 2017 Feb; 18(3):263-273.
    View in: PubMed
    Score: 0.436
  35. Faulks SW, Feldman SR. Presenting treatment safety data: subjective interpretations of objective information. Cutis. 2016 Oct; 98(4):259-262.
    View in: PubMed
    Score: 0.427
  36. Kagha KC, Blauvelt A, Anderson KL, Leonardi CL, Feldman SR. A boxed warning for inadequate psoriasis treatment. Cutis. 2016 Sep; 98(3):206-207.
    View in: PubMed
    Score: 0.425
  37. Feldman SR, Levi E, Pathak P, Kakatkar S, Balkrishnan R. First-Line Fixed-Combination Psoriasis Treatment Is Associated With Lower Healthcare Costs. Skinmed. 2016; 14(4):266-272.
    View in: PubMed
    Score: 0.422
  38. Cline A, Hill D, Lewallen R, Feldman SR. Current status and future prospects for biologic treatments of psoriasis. Expert Rev Clin Immunol. 2016 Dec; 12(12):1273-1287.
    View in: PubMed
    Score: 0.420
  39. Pena S, Hill D, Feldman SR. Use of topical retinoids by dermatologists and non-dermatologists in the management of acne vulgaris. J Am Acad Dermatol. 2016 Jun; 74(6):1252-4.
    View in: PubMed
    Score: 0.417
  40. Hoffman MB, Hill D, Feldman SR. Current challenges and emerging drug delivery strategies for the treatment of psoriasis. Expert Opin Drug Deliv. 2016 Oct; 13(10):1461-73.
    View in: PubMed
    Score: 0.417
  41. Ahn CS, Culp L, Huang WW, Davis SA, Feldman SR. Adherence in dermatology. J Dermatolog Treat. 2017 Mar; 28(2):94-103.
    View in: PubMed
    Score: 0.416
  42. Kin KC, Hill D, Feldman SR. Calcipotriene and betamethasone dipropionate for the topical treatment of plaque psoriasis. Expert Rev Clin Pharmacol. 2016 Jun; 9(6):789-97.
    View in: PubMed
    Score: 0.416
  43. James SM, Hill DE, Feldman SR. Costs of Common Psoriasis Medications, 2010-2014. J Drugs Dermatol. 2016 Mar; 15(3):305-8.
    View in: PubMed
    Score: 0.410
  44. Smith JA, Narahari S, Hill D, Feldman SR. Tazarotene foam, 0.1%, for the treatment of acne. Expert Opin Drug Saf. 2016 Jan; 15(1):99-103.
    View in: PubMed
    Score: 0.403
  45. Rouse NC, Farhangian ME, Wehausen B, Feldman SR. The cost-effectiveness of ustekinumab for moderate-to-severe psoriasis. Expert Rev Pharmacoecon Outcomes Res. 2015; 15(6):877-84.
    View in: PubMed
    Score: 0.400
  46. Feldman SR, Zhao Y, Shi L, Tran MH. Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis. J Manag Care Spec Pharm. 2015 Oct; 21(10):874-88.
    View in: PubMed
    Score: 0.398
  47. Feldman SR, Anderson K. In Reply. JAMA Dermatol. 2015 Oct; 151(10):1145.
    View in: PubMed
    Score: 0.398
  48. Farhangian ME, Feldman SR. Immunogenicity of biologic treatments for psoriasis: therapeutic consequences and the potential value of concomitant methotrexate. Am J Clin Dermatol. 2015 Aug; 16(4):285-294.
    View in: PubMed
    Score: 0.394
  49. Culp L, Moradi Tuchayi S, Alinia H, Feldman SR. Tolerability of Topical Retinoids: Are There Clinically Meaningful Differences Among Topical Retinoids? J Cutan Med Surg. 2015 Nov-Dec; 19(6):530-8.
    View in: PubMed
    Score: 0.390
  50. Anderson KL, Dothard EH, Huang KE, Feldman SR. Frequency of Primary Nonadherence to Acne Treatment. JAMA Dermatol. 2015 Jun; 151(6):623-6.
    View in: PubMed
    Score: 0.389
  51. Aslam I, Fleischer A, Feldman S. Emerging drugs for the treatment of acne. Expert Opin Emerg Drugs. 2015 Mar; 20(1):91-101.
    View in: PubMed
    Score: 0.376
  52. Moustafa FA, Sandoval LF, Feldman SR. Rosacea: new and emerging treatments. Drugs. 2014 Sep; 74(13):1457-65.
    View in: PubMed
    Score: 0.370
  53. Feldman SR. Psoriasis: the new and the old. J Drugs Dermatol. 2014 Aug; 13(8):894.
    View in: PubMed
    Score: 0.367
  54. Sandoval LF, Pierce A, Feldman SR. Systemic therapies for psoriasis: an evidence-based update. Am J Clin Dermatol. 2014 Jul; 15(3):165-80.
    View in: PubMed
    Score: 0.365
  55. Parikh SA, Davis SA, Krowchuk DP, Feldman SR. Common use of prescription off-label acne therapy in children younger than 12 years old. Pediatr Dermatol. 2014 Sep-Oct; 31(5):551-5.
    View in: PubMed
    Score: 0.364
  56. Carstensen SE, Huang KE, Feldman SR. Treatment failure of patients using topical acne treatments: an observational retrospective cohort study. J Dermatolog Treat. 2014 Jun; 25(3):193-5.
    View in: PubMed
    Score: 0.363
  57. Feldman SR, Huang WW, Huynh TT. Current drug therapies for rosacea: a chronic vascular and inflammatory skin disease. J Manag Care Spec Pharm. 2014 Jun; 20(6):623-9.
    View in: PubMed
    Score: 0.363
  58. Huang KE, Carstensen SE, Feldman SR. The duration of acne treatment. J Drugs Dermatol. 2014 Jun; 13(6):655-6.
    View in: PubMed
    Score: 0.363
  59. Tan X, Davis SA, Balkrishnan R, Krowchuk DP, Feldman SR. Factors associated with topical retinoid prescriptions for acne. J Dermatolog Treat. 2014 Apr; 25(2):110-4.
    View in: PubMed
    Score: 0.359
  60. Snyder S, Crandell I, Davis SA, Feldman SR. Medical adherence to acne therapy: a systematic review. Am J Clin Dermatol. 2014 Apr; 15(2):87-94.
    View in: PubMed
    Score: 0.359
  61. Semble AL, Davis SA, Feldman SR. Safety and tolerability of tumor necrosis factor-a inhibitors in psoriasis: a narrative review. Am J Clin Dermatol. 2014 Feb; 15(1):37-43.
    View in: PubMed
    Score: 0.355
  62. Sandoval LF, Semble A, Gustafson CJ, Huang KE, Levender MM, Feldman SR. Pilot randomized-control trial to assess the effect product sampling has on adherence using adapalene/benzoyl peroxide gel in acne patients. J Drugs Dermatol. 2014 Feb; 13(2):135-40.
    View in: PubMed
    Score: 0.355
  63. Feldman SR, Winkelman W, Baum E, Preston N. Predicting improvement in signs and symptoms of plaque psoriasis after 1 week of treatment with clobetasol propionate 0.05% spray. J Drugs Dermatol. 2013 Dec; 12(12):1456-60.
    View in: PubMed
    Score: 0.351
  64. Sandoval LF, Hartel JK, Feldman SR. Current and future evidence-based acne treatment: a review. Expert Opin Pharmacother. 2014 Feb; 15(2):173-92.
    View in: PubMed
    Score: 0.351
  65. Feldman SR, Levi E, Pathak P, Kakatkar S, Balkrishnan R. Using a single product (calcipotriene/betamethasone topical suspension) vs multiple products to manage body and scalp psoriasis: comparisons in resource utilization and costs. J Med Econ. 2013 Dec; 16(12):1405-13.
    View in: PubMed
    Score: 0.348
  66. Zargari O, Hejazi S, Shahidi-Dadras M, Younespour S, Robati R, Firooz A, Toosi P, Feldman SR. Considerable variation among Iranian dermatologists in the dosing and monitoring of methotrexate for treating psoriasis. Int J Dermatol. 2014 Mar; 53(3):385-9.
    View in: PubMed
    Score: 0.348
  67. Feldman SR. The continued evolution of drugs for psoriasis. J Drugs Dermatol. 2013 Aug; 12(8):850-1.
    View in: PubMed
    Score: 0.343
  68. Akamine KL, Gustafson CJ, Yentzer BA, Edison BL, Green BA, Davis SA, Feldman SR. A double-blind, randomized clinical trial of 20% alpha/poly hydroxy acid cream to reduce scaling of lesions associated with moderate, chronic plaque psoriasis. J Drugs Dermatol. 2013 Aug; 12(8):855-9.
    View in: PubMed
    Score: 0.343
  69. Ahn CS, Awadalla F, Huang KE, Yentzer B, Dabade TS, Feldman SR. Patterns of vitamin D analog use for the treatment of psoriasis. J Drugs Dermatol. 2013 Aug; 12(8):906-10.
    View in: PubMed
    Score: 0.343
  70. Sandoval LF, Davis SA, Feldman SR. Dermatologists' knowledge of and preferences regarding topical steroids. J Drugs Dermatol. 2013 Jul 01; 12(7):786-9.
    View in: PubMed
    Score: 0.341
  71. Davis SA, Feldman SR. Combination therapy for psoriasis in the United States. J Drugs Dermatol. 2013 May; 12(5):546-50.
    View in: PubMed
    Score: 0.337
  72. Feldman SR. Patients are often terrified of treatments. J Dermatolog Treat. 2013 Apr; 24(2):81.
    View in: PubMed
    Score: 0.335
  73. Feldman SR, Werner CP, Alió Saenz AB. The efficacy and tolerability of tazarotene foam, 0.1%, in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle-controlled, double-blind studies. J Drugs Dermatol. 2013 Apr; 12(4):438-46.
    View in: PubMed
    Score: 0.335
  74. Feldman SR, Mills M, Brundage T, Eastman WJ. A multicenter, randomized, double-blind study of the efficacy and safety of calcipotriene foam, 0.005%, vs vehicle foam in the treatment of plaque-type psoriasis of the scalp. J Drugs Dermatol. 2013 Mar; 12(3):300-6.
    View in: PubMed
    Score: 0.333
  75. Gustafson CJ, Watkins C, Hix E, Feldman SR. Combination therapy in psoriasis: an evidence-based review. Am J Clin Dermatol. 2013 Feb; 14(1):9-25.
    View in: PubMed
    Score: 0.331
  76. Fenerty SD, O'Neill JL, Gustafson CJ, Feldman SR. Maternal adherence factors in the treatment of pediatric atopic dermatitis. JAMA Dermatol. 2013 Feb; 149(2):229-31.
    View in: PubMed
    Score: 0.331
  77. Tripathi SV, Gustafson CJ, Huang KE, Feldman SR. Side effects of common acne treatments. Expert Opin Drug Saf. 2013 Jan; 12(1):39-51.
    View in: PubMed
    Score: 0.327
  78. Feldman SR, Matheson R, Bruce S, Grande K, Markowitz O, Kempers S, Brundage T, Wyres M. Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type psoriasis: results of two multicenter, randomized, double-blind, vehicle-controlled, phase III clinical trials. Am J Clin Dermatol. 2012 Aug 01; 13(4):261-71.
    View in: PubMed
    Score: 0.320
  79. Feldman SR, Fried RG, Herndon JH, Johnson L, Preston N, Gottschalk RW, Caveney SW. Digital videography assessment of patients' experiences using adapalene-benzoyl peroxide gel in the treatment of acne vulgaris. J Drugs Dermatol. 2012 Aug; 11(8):919-25.
    View in: PubMed
    Score: 0.320
  80. Landis ET, Levender MM, Davis SA, Feneran AN, Gerancher KR, Feldman SR. Isotretinoin and oral contraceptive use in female acne patients varies by physician specialty: analysis of data from the National Ambulatory Medical Care Survey. J Dermatolog Treat. 2012 Aug; 23(4):272-7.
    View in: PubMed
    Score: 0.313
  81. Smith SF, Feldman SR. Tattoo sites and psoriasis. J Drugs Dermatol. 2011 Oct; 10(10):1199-200.
    View in: PubMed
    Score: 0.302
  82. Yentzer BA, Wood AA, Sagransky MJ, O'Neill JL, Clark AR, Williams LL, Feldman SR. An Internet-based survey and improvement of acne treatment outcomes. Arch Dermatol. 2011 Oct; 147(10):1223-4.
    View in: PubMed
    Score: 0.302
  83. Staidle JP, Dabade TS, Feldman SR. A pharmacoeconomic analysis of severe psoriasis therapy: a review of treatment choices and cost efficiency. Expert Opin Pharmacother. 2011 Sep; 12(13):2041-54.
    View in: PubMed
    Score: 0.297
  84. Feldman SR, Chen DM. How patients experience and manage dryness and irritation from acne treatment. J Drugs Dermatol. 2011 Jun; 10(6):605-8.
    View in: PubMed
    Score: 0.295
  85. Dabade TS, Feldman SR. We must think outside the box to understand nonadherence. Pediatr Dermatol. 2011 May-Jun; 28(3):353.
    View in: PubMed
    Score: 0.293
  86. Yentzer BA, Gosnell AL, Clark AR, Pearce DJ, Balkrishnan R, Camacho FT, Young TA, Fountain JM, Fleischer AB, Colón LE, Johnson LA, Preston N, Feldman SR. A randomized controlled pilot study of strategies to increase adherence in teenagers with acne vulgaris. J Am Acad Dermatol. 2011 Apr; 64(4):793-5.
    View in: PubMed
    Score: 0.292
  87. Feldman SR, Tan J, Poulin Y, Dirschka T, Kerrouche N, Manna V. The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions. J Am Acad Dermatol. 2011 Jun; 64(6):1085-91.
    View in: PubMed
    Score: 0.291
  88. Shah A, O'Neill J, Feldman SR. Treatment of moderate-to-severe psoriasis with alefacept for up to one year: a case series. J Drugs Dermatol. 2010 Dec; 9(12):1491-4.
    View in: PubMed
    Score: 0.285
  89. Rajpara AN, Feldman SR. Adherence to treatment: still the forgotten variable. Arch Dermatol. 2010 Oct; 146(10):1183-4; author reply 1184.
    View in: PubMed
    Score: 0.282
  90. Alikhan A, Daly M, Wu J, Balkrishnan R, Feldman SR. Cost-effectiveness of a hydroquinone/tretinoin/fluocinolone acetonide cream combination in treating melasma in the United States. J Dermatolog Treat. 2010 Sep; 21(5):276-81.
    View in: PubMed
    Score: 0.280
  91. Anis AH, Bansback N, Sizto S, Gupta SR, Willian MK, Feldman SR. Economic evaluation of biologic therapies for the treatment of moderate to severe psoriasis in the United States. J Dermatolog Treat. 2011 Apr; 22(2):65-74.
    View in: PubMed
    Score: 0.274
  92. Balkrishnan R, Bhosle MJ, Fleischer AB, Feldman SR. Prior authorization for topical psoriasis treatments: is it cost-beneficial for managed care? J Dermatolog Treat. 2010 May; 21(3):178-84.
    View in: PubMed
    Score: 0.274
  93. Alikhan A, Sockolov M, Brodell RT, Feldman SR. Drug samples in dermatology: special considerations and recommendations for the future. J Am Acad Dermatol. 2010 Jun; 62(6):1053-61.
    View in: PubMed
    Score: 0.270
  94. Nolan BV, Feldman SR. Adherence, the fourth dimension in the geometry of dermatological treatment. Arch Dermatol. 2009 Nov; 145(11):1319-21.
    View in: PubMed
    Score: 0.264
  95. Sagransky M, Yentzer BA, Feldman SR. Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris. Expert Opin Pharmacother. 2009 Oct; 10(15):2555-62.
    View in: PubMed
    Score: 0.263
  96. Yentzer BA, McClain RW, Feldman SR. Do topical retinoids cause acne to "flare"? J Drugs Dermatol. 2009 Sep; 8(9):799-801.
    View in: PubMed
    Score: 0.261
  97. Fakhouri T, Yentzer BA, Feldman SR. Advancement in benzoyl peroxide-based acne treatment: methods to increase both efficacy and tolerability. J Drugs Dermatol. 2009 Jul; 8(7):657-61.
    View in: PubMed
    Score: 0.258
  98. Zivkovich AH, Feldman SR. Are ointments better than other vehicles for corticosteroid treatment of psoriasis? J Drugs Dermatol. 2009 Jun; 8(6):570-2.
    View in: PubMed
    Score: 0.257
  99. Nolan BV, Feldman SR. Dermatologic medication adherence. Dermatol Clin. 2009 Apr; 27(2):113-20, v.
    View in: PubMed
    Score: 0.254
  100. Wilson R, Camacho F, Clark AR, Young T, Inabinet R, Yentzer BA, Feldman SR. Adherence to topical hydrocortisone 17-butyrate 0.1% in different vehicles in adults with atopic dermatitis. J Am Acad Dermatol. 2009 Jan; 60(1):166-8.
    View in: PubMed
    Score: 0.250
  101. Alikhan A, Sodhi N, Feldman SR. Equating topical treatment of severe psoriasis to keeping money in a mattress. J Dermatolog Treat. 2009; 20(1):1-2.
    View in: PubMed
    Score: 0.250
  102. Lucas J, Ntuen E, Pearce DJ, Fleischer AB, Feldman SR. Methotrexate: understanding the risk in psoriasis patients. J Dermatolog Treat. 2009; 20(5):311-3.
    View in: PubMed
    Score: 0.250
  103. Feldman SR. Adherence must always be considered: is everolimus really ineffective as a treatment for atopic dermatitis? J Dermatolog Treat. 2009; 20(6):317-8.
    View in: PubMed
    Score: 0.250
  104. Strowd LC, Yentzer BA, Fleischer AB, Feldman SR. Increasing use of more potent treatments for psoriasis. J Am Acad Dermatol. 2009 Mar; 60(3):478-81.
    View in: PubMed
    Score: 0.248
  105. Carr D, Tusa MG, Carroll CL, Pearce DJ, Camacho F, Kaur M, Cook C, Willard J, McCarty A, Fleischer AB, Liu CM, Goffe BS, Feldman SR. Open label trial of alefacept in palmoplantar pustular psoriasis. J Dermatolog Treat. 2008; 19(2):97-100.
    View in: PubMed
    Score: 0.233
  106. Feldman SR, Fleischer AB. A method to gain a sense of relative efficacy of acne medications that have not yet been studied. J Drugs Dermatol. 2007 Oct; 6(10):976.
    View in: PubMed
    Score: 0.229
  107. Conde JF, Yelverton CB, Balkrishnan R, Fleischer AB, Feldman SR. Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics. J Drugs Dermatol. 2007 May; 6(5):495-8.
    View in: PubMed
    Score: 0.222
  108. Feldman SR. Misunderstandings. J Dermatolog Treat. 2007; 18(1):4.
    View in: PubMed
    Score: 0.217
  109. Feldman SR. What you should do when people don't get well. J Dermatolog Treat. 2007; 18(4):196.
    View in: PubMed
    Score: 0.217
  110. Warino L, Balkrishnan R, Feldman SR. Clobetasol propionate for psoriasis: are ointments really more potent? J Drugs Dermatol. 2006 Jun; 5(6):527-32.
    View in: PubMed
    Score: 0.209
  111. Krejci-Manwaring J, McCarty MA, Camacho F, Carroll CL, Johnson K, Manuel J, Balkrishnan R, Hartle J, Fleischer A, Feldman SR. Adherence with topical treatment is poor compared with adherence with oral agents: implications for effective clinical use of topical agents. J Am Acad Dermatol. 2006 May; 54(5 Suppl):S235-6.
    View in: PubMed
    Score: 0.207
  112. Kirkland CR, Yelverton CB, Fleischer AB, Camacho FT, Feldman SR. Gel vehicles are not inherently more irritating than creams. J Drugs Dermatol. 2006 Mar; 5(3):269-72.
    View in: PubMed
    Score: 0.205
  113. Miller DW, Feldman SR. Cost-effectiveness of moderate-to-severe psoriasis treatment. Expert Opin Pharmacother. 2006 Feb; 7(2):157-67.
    View in: PubMed
    Score: 0.204
  114. Nelson AA, Pearce DJ, Fleischer AB, Balkrishnan R, Feldman SR. New treatments for psoriasis: which biologic is best? J Dermatolog Treat. 2006; 17(2):96-107.
    View in: PubMed
    Score: 0.203
  115. Pearce DJ, Higgins KB, Stealey KH, Balkrishnan R, Crane MM, Camacho F, Fleischer AB, Feldman SR. Adverse events from systemic therapies for psoriasis are common in clinical practice. J Dermatolog Treat. 2006; 17(5):288-93.
    View in: PubMed
    Score: 0.203
  116. Pearce DJ, Camacho F, Balkrishnan R, Fleischer AB, Feldman SR. Trends in on and off-label calcipotriene use. J Dermatolog Treat. 2006; 17(5):308-13.
    View in: PubMed
    Score: 0.203
  117. Ziel K, Yelverton CB, Balkrishnan R, Feldman SR. Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skin. J Drugs Dermatol. 2005 Nov-Dec; 4(6):727-31.
    View in: PubMed
    Score: 0.200
  118. Kulkarni AS, Balkrishnan R, Richmond D, Pearce DJ, Feldman SR. Medication-related factors affecting health care outcomes and costs for patients with psoriasis in the United States. J Am Acad Dermatol. 2005 Jan; 52(1):27-31.
    View in: PubMed
    Score: 0.189
  119. Jordan AY, Parks L, Chen SC, Higgins K, Fleischer AB, Feldman SR. Does the teratogenicity of isotretinoin outweigh its benefits? J Dermatolog Treat. 2005; 16(4):190-2.
    View in: PubMed
    Score: 0.189
  120. Bhosle M, Balkrishnan R, Dewan T, Yelverton CB, Feldman SR. The rise of the generic drug market and its implications for dermatology. J Dermatolog Treat. 2005; 16(5-6):295-8.
    View in: PubMed
    Score: 0.189
  121. Nelson AA, Pearce DJ, Fleischer AB, Balkrishnan R, Feldman SR. Infliximab for inpatient psoriasis management--is there a role? J Dermatolog Treat. 2005; 16(5-6):314-8.
    View in: PubMed
    Score: 0.189
  122. Hu J, Balkrishnan R, Camacho F, Lang W, Pearce DJ, Fleischer AB, Feldman SR. The frequent use of oral retinoids in combination with other treatments for psoriasis: a retrospective analysis. J Cutan Med Surg. 2004 Nov-Dec; 8(6):411-4.
    View in: PubMed
    Score: 0.187
  123. Feldman SR. The moral of the isotretinoin depression story. J Dermatolog Treat. 2004 Jul; 15(4):199.
    View in: PubMed
    Score: 0.183
  124. Fleischer AB, Simpson JK, McMichael A, Feldman SR. Are there racial and sex differences in the use of oral isotretinoin for acne management in the United States? J Am Acad Dermatol. 2003 Oct; 49(4):662-6.
    View in: PubMed
    Score: 0.173
  125. Feldman SR, Garton R, Averett W, Balkrishnan R, Vallee J. Strategy to manage the treatment of severe psoriasis: considerations of efficacy, safety and cost. Expert Opin Pharmacother. 2003 Sep; 4(9):1525-33.
    View in: PubMed
    Score: 0.172
  126. Housman TS, Mellen BG, Rapp SR, Fleischer AB, Feldman SR. Patients with psoriasis prefer solution and foam vehicles: a quantitative assessment of vehicle preference. Cutis. 2002 Dec; 70(6):327-32.
    View in: PubMed
    Score: 0.164
  127. Gao JC, Emmerich VK, Feldman S, Strowd LC. Evaluating calcipotriene 0.005% foam for the treatment of plaque psoriasis of the scalp and body in patients aged 12 years and older. Expert Opin Pharmacother. 2021 Apr; 22(5):543-547.
    View in: PubMed
    Score: 0.142
  128. Freeze ME, Balogh EA, Cline A, Feldman SR, Fleischer AB. Comparing prescribing patterns for topical corticosteroids based on their FDA indication by age. Pediatr Dermatol. 2021 Jan; 38(1):115-118.
    View in: PubMed
    Score: 0.142
  129. Newsom M, Bashyam AM, Balogh EA, Feldman SR, Strowd LC. New and Emerging Systemic Treatments for Atopic Dermatitis. Drugs. 2020 Jul; 80(11):1041-1052.
    View in: PubMed
    Score: 0.138
  130. Bray JK, Cline A, Masicampo EJ, Kammrath L, Feldman SR. Comparing psoriasis advertisement methods with patient willingness to initiate treatment. J Dermatolog Treat. 2020 Sep; 31(6):626-630.
    View in: PubMed
    Score: 0.132
  131. Langley RGB, Reich K, Strand V, Feldman SR, Paul C, Gordon K, Warren RB, Toth D, Nikaï E, Zhu B, Goldblum O, Edson-Heredia E, Carlier H, Burge R, Lin CY, Hollister K, Augustin M. Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis. Qual Life Res. 2020 Feb; 29(2):369-380.
    View in: PubMed
    Score: 0.132
  132. Stiff KM, Glines KR, Porter CL, Cline A, Feldman SR. Current pharmacological treatment guidelines for psoriasis and psoriatic arthritis. Expert Rev Clin Pharmacol. 2018 Dec; 11(12):1209-1218.
    View in: PubMed
    Score: 0.124
  133. Heath MS, Sahni DR, Curry ZA, Feldman SR. Pharmacokinetics of tazarotene and acitretin in psoriasis. Expert Opin Drug Metab Toxicol. 2018 Sep; 14(9):919-927.
    View in: PubMed
    Score: 0.122
  134. Wu JJ, Feldman SR, Rastogi S, Menges B, Lingohr-Smith M, Lin J. Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United States. J Dermatolog Treat. 2018 Dec; 29(8):769-774.
    View in: PubMed
    Score: 0.119
  135. Edwards T, Patel NU, Blake A, Prabakaran S, Reimer D, Feldman SR, Strowd LC. Insights into future therapeutics for atopic dermatitis. Expert Opin Pharmacother. 2018 02; 19(3):265-278.
    View in: PubMed
    Score: 0.117
  136. Shukla S, Feldman SR, Strowd LC. A safety review of the medications used to treat atopic dermatitis. Expert Opin Drug Saf. 2018 02; 17(2):179-183.
    View in: PubMed
    Score: 0.116
  137. Skaggs RL, Hix E, Huang KE, Feldman SR. Characterization of Patients' Quality of Life and Experience in the Course of Acne Treatment. Skinmed. 2017; 15(6):431-435.
    View in: PubMed
    Score: 0.116
  138. Feldman SR, Cardwell LA, Taylor SL. Complexities of Rosacea. Dermatol Clin. 2018 Apr; 36(2):xiii.
    View in: PubMed
    Score: 0.115
  139. Patel NU, Shukla S, Zaki J, Feldman SR. Oxymetazoline hydrochloride cream for facial erythema associated with rosacea. Expert Rev Clin Pharmacol. 2017 Oct; 10(10):1049-1054.
    View in: PubMed
    Score: 0.114
  140. Smith JA, Wehausen B, Richardson I, Zhao Y, Li Y, Herrera V, Feldman SR. Treatment Changes in Patients With Moderate to Severe Psoriasis: A Retrospective Chart Review. J Cutan Med Surg. 2018 Jan/Feb; 22(1):25-30.
    View in: PubMed
    Score: 0.113
  141. Asche CV, Kim M, Feldman SR, Zografos P, Lu M. Budget impact model in moderate-to-severe psoriasis vulgaris assessing effects of calcipotriene and betamethasone dipropionate foam on per-patient standard of care costs. J Med Econ. 2017 Sep; 20(9):1000-1006.
    View in: PubMed
    Score: 0.112
  142. Davis SA, Himmler S, Feldman SR. Cost-effectiveness analysis of using dermatologists versus pediatricians to treat mild to moderate acne. Dermatol Online J. 2017 May 15; 23(5).
    View in: PubMed
    Score: 0.111
  143. Feldman SR, Zhao Y, Zhou H, Herrera V, Tian H, Li Y. Economic Impact of Above-Label Dosing with Etanercept, Adalimumab, or Ustekinumab in Patients with Psoriasis. J Manag Care Spec Pharm. 2017 May; 23(5):583-589.
    View in: PubMed
    Score: 0.111
  144. Smith J, Cline A, Feldman SR. Advances in Psoriasis. South Med J. 2017 01; 110(1):65-75.
    View in: PubMed
    Score: 0.109
  145. Alghanem N, Abokwidir M, Fleischer AB, Feldman SR, Alghanem W. Variation in cash price of the generic medications most prescribed by dermatologists in pharmacies across the United States. J Dermatolog Treat. 2017 Mar; 28(2):119-128.
    View in: PubMed
    Score: 0.104
  146. Feldman SR, Bushnell DM, Klekotka PA, Scanlon M, Martin ML, Wade SW, Yang W, Pinto L, Kircik L, Viswanathan HN. Differences in psoriasis signs and symptom severity between patients with clear and almost clear skin in clinical practice. J Dermatolog Treat. 2016; 27(3):224-7.
    View in: PubMed
    Score: 0.100
  147. Vaidya TS, Anderson KL, Feldman SR. Even well-controlled psoriasis patients have unmet treatment needs regardless of disease severity. Dermatol Online J. 2015 Sep 17; 21(9).
    View in: PubMed
    Score: 0.099
  148. Feldman SR. New Frontiers in Psoriasis Treatment. J Drugs Dermatol. 2015 Aug; 14(8):776.
    View in: PubMed
    Score: 0.098
  149. Taheri A, Moradi Tuchayi S, Alinia H, Orscheln CS, Mansoori P, Feldman SR. Topical clobetasol in conjunction with topical tretinoin is effective in preventing scar formation after superficial partial-thickness burn ulcers of the skin: A retrospective study. J Dermatolog Treat. 2015; 26(4):361-4.
    View in: PubMed
    Score: 0.094
  150. Sandoval LF, Huang KE, Harrison J, Clark A, Feldman SR. Calcipotriene 0.005%--betamethasone dipropionate 0.064% ointment versus topical suspension in the treatment of plaque psoriasis: a randomized pilot study of patient preference. Cutis. 2014 Dec; 94(6):304-9.
    View in: PubMed
    Score: 0.094
  151. Sidbury R, Tom WL, Bergman JN, Cooper KD, Silverman RA, Berger TG, Chamlin SL, Cohen DE, Cordoro KM, Davis DM, Feldman SR, Hanifin JM, Krol A, Margolis DJ, Paller AS, Schwarzenberger K, Simpson EL, Williams HC, Elmets CA, Block J, Harrod CG, Smith Begolka W, Eichenfield LF. Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol. 2014 Dec; 71(6):1218-33.
    View in: PubMed
    Score: 0.093
  152. Shaw MK, Davis SA, Feldman SR, Fleischer AB. Trends in systemic psoriasis treatment therapies from 1993 through 2010. J Drugs Dermatol. 2014 Aug; 13(8):917-20.
    View in: PubMed
    Score: 0.092
  153. Bartlett KB, Davis SA, Feldman SR. Tolerability of topical antimicrobials in treatment of acne vulgaris. J Drugs Dermatol. 2014 Jun; 13(6):658-62.
    View in: PubMed
    Score: 0.091
  154. Mauskopf J, Samuel M, McBride D, Mallya UG, Feldman SR. Treatment sequencing after failure of the first biologic in cost-effectiveness models of psoriasis: a systematic review of published models and clinical practice guidelines. Pharmacoeconomics. 2014 Apr; 32(4):395-409.
    View in: PubMed
    Score: 0.090
  155. Tan X, Balkrishnan R, Feldman SR. Infections associated with the use of tumor necrosis factor-a inhibitors in psoriasis. J Drugs Dermatol. 2013 Mar; 12(3):e41-5.
    View in: PubMed
    Score: 0.083
  156. Heaton E, Levender MM, Feldman SR. Timing of office visits can be a powerful tool to improve adherence in the treatment of dermatologic conditions. J Dermatolog Treat. 2013 Apr; 24(2):82-8.
    View in: PubMed
    Score: 0.083
  157. Feldman SR. Department of Dermatology was blessed with a wonderful psoriasis specialist. Foreword. BioDrugs. 2013 Jan; 27 Suppl 1:1-2.
    View in: PubMed
    Score: 0.082
  158. Kim IH, West CE, Kwatra SG, Feldman SR, O'Neill JL. Comparative efficacy of biologics in psoriasis: a review. Am J Clin Dermatol. 2012 Dec 01; 13(6):365-74.
    View in: PubMed
    Score: 0.082
  159. Kwatra SG, Feldman SR. A dermatologist's dilemma: treatment failure or failure to treat? Cutis. 2012 Nov; 90(5):219-20.
    View in: PubMed
    Score: 0.081
  160. Ghasri P, Yentzer BA, Dabade TS, Feldman SR. Acitretin for the treatment of psoriasis: an assessment of national trends. J Drugs Dermatol. 2011 Aug; 10(8):873-7.
    View in: PubMed
    Score: 0.075
  161. Searles AD, Lee AD, Feldman SR. Is concomitant use of methotrexate and oral retinoids dangerous? A review of the data regarding this combination. J Am Acad Dermatol. 2011 Apr; 64(4):791-3.
    View in: PubMed
    Score: 0.073
  162. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, Koo JY, Lebwohl M, Leonardi CL, Lim HW, Van Voorhees AS, Beutner KR, Ryan C, Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol. 2011 Jul; 65(1):137-74.
    View in: PubMed
    Score: 0.072
  163. Lin HC, Lucas PT, Feldman SR, Balkrishnan R. Medication use and associated health care outcomes and costs for patients with psoriasis in the United States. J Dermatolog Treat. 2012 Jun; 23(3):196-202.
    View in: PubMed
    Score: 0.072
  164. Zeichner JA, Lebwohl MG, Menter A, Bagel J, Del Rosso JQ, Elewski BE, Feldman SR, Kircik LH, Koo J, Gold LS, Tanghetti E. Optimizing topical therapies for treating psoriasis: a consensus conference. Cutis. 2010 Sep; 86(3 Suppl):5-31; quiz 32.
    View in: PubMed
    Score: 0.070
  165. Kinney MA, Yentzer BA, Fleischer AB, Feldman SR. Trends in the treatment of acne vulgaris: are measures being taken to avoid antimicrobial resistance? J Drugs Dermatol. 2010 May; 9(5):519-24.
    View in: PubMed
    Score: 0.068
  166. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb AB, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009 Sep; 61(3):451-85.
    View in: PubMed
    Score: 0.064
  167. Al-Kudwah AJ, Feldman SR. Management of psoriasis. South Med J. 2009 Jun; 102(6):631-6.
    View in: PubMed
    Score: 0.064
  168. Yentzer BA, Irby CE, Fleischer AB, Feldman SR. Differences in acne treatment prescribing patterns of pediatricians and dermatologists: an analysis of nationally representative data. Pediatr Dermatol. 2008 Nov-Dec; 25(6):635-9.
    View in: PubMed
    Score: 0.062
  169. Inglese MJ, Fleischer AB, Feldman SR, Balkrishnan R. The pharmacoeconomics of acne treatment: where are we heading? J Dermatolog Treat. 2008; 19(1):27-37.
    View in: PubMed
    Score: 0.058
  170. Pearce DJ, Stealey KH, Balkrishnan R, Fleischer AB, Feldman SR. Psoriasis treatment in the United States at the end of the 20th century. Int J Dermatol. 2006 Apr; 45(4):370-4.
    View in: PubMed
    Score: 0.052
  171. Pearce DJ, Nelson AA, Fleischer AB, Balkrishnan R, Feldman SR. The cost-effectiveness and cost of treatment failures associated with systemic psoriasis therapies. J Dermatolog Treat. 2006; 17(1):29-37.
    View in: PubMed
    Score: 0.051
  172. Lebwohl M, Freeman A, Chapman MS, Feldman S, Hartle J, Henning A. Proven efficacy of tacrolimus for facial and intertriginous psoriasis. Arch Dermatol. 2005 Sep; 141(9):1154.
    View in: PubMed
    Score: 0.050
  173. Lowe N, Feldman SR, Sherer D, Weiss J, Shavin JS, Lin YL, Foley V, Soto P. Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis. J Dermatolog Treat. 2005 Aug; 16(3):158-64.
    View in: PubMed
    Score: 0.049
  174. Marchetti A, Feldman SR, Kimball AB, Anderson RR, Miller LH, Martin J, An P. Treatments for mild-to-moderate recalcitrant plaque psoriasis: expected clinical and economic outcomes for first-line and second-line care. Dermatol Online J. 2005 Mar 01; 11(1):1.
    View in: PubMed
    Score: 0.048
  175. Leonardi CL, Papp KA, Gordon KB, Menter A, Feldman SR, Caro I, Walicke PA, Compton PG, Gottlieb AB. Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial. J Am Acad Dermatol. 2005 Mar; 52(3 Pt 1):425-33.
    View in: PubMed
    Score: 0.048
  176. Nijsten T, Margolis DJ, Feldman SR, Rolstad T, Stern RS. Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey. J Am Acad Dermatol. 2005 Mar; 52(3 Pt 1):434-44.
    View in: PubMed
    Score: 0.048
  177. Lebwohl M, Freeman AK, Chapman MS, Feldman SR, Hartle JE, Henning A. Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol. 2004 Nov; 51(5):723-30.
    View in: PubMed
    Score: 0.047
  178. Cayce KA, McMichael AJ, Feldman SR. Hyperpigmentation: an overview of the common afflictions. Dermatol Nurs. 2004 Oct; 16(5):401-6, 413-6; quiz 417.
    View in: PubMed
    Score: 0.046
  179. Pearce DJ, Thomas CG, Fleischer AB, Feldman SR. The cost of psoriasis therapies: considerations for therapy selection. Dermatol Nurs. 2004 Oct; 16(5):421-8, 432.
    View in: PubMed
    Score: 0.046
  180. Balkrishnan R, Cook JM, Shaffer MP, Saltzberg FB, Feldman SR, Fleischer AB. Analysis of factors associated with prescription of a potentially inappropriate combination dermatological medication among US outpatient physicians. Pharmacoepidemiol Drug Saf. 2004 Mar; 13(3):133-8.
    View in: PubMed
    Score: 0.045
  181. Feldman S. Modest innovations in psoriasis treatment? J Dermatolog Treat. 2003 Dec; 14(4):198-9.
    View in: PubMed
    Score: 0.044
  182. Menter MA, Krueger GC, Feldman SR, Weinstein GD. Psoriasis treatment 2003 at the new millennium: position paper on behalf of the authors. J Am Acad Dermatol. 2003 Aug; 49(2 Suppl):S39-43.
    View in: PubMed
    Score: 0.043
  183. Bruner CR, Feldman SR, Ventrapragada M, Fleischer AB. A systematic review of adverse effects associated with topical treatments for psoriasis. Dermatol Online J. 2003 Feb; 9(1):2.
    View in: PubMed
    Score: 0.041
  184. Lebwohl M, Menter A, Koo J, Feldman S. Case studies in severe psoriasis: A clinical strategy. J Dermatolog Treat. 2003; 14 Suppl 2:26-46.
    View in: PubMed
    Score: 0.041
  185. He A, Feldman SR, Fleischer AB. Trends in Atopic Dermatitis Management: Comparison of 1990-1997 to 2003-2012. J Drugs Dermatol. 2018 Feb 01; 17(2):135-140.
    View in: PubMed
    Score: 0.029
  186. Kang SJ, Davis SA, Feldman SR, McMichael AJ. Dyschromia in skin of color. J Drugs Dermatol. 2014 Apr; 13(4):401-6.
    View in: PubMed
    Score: 0.022
  187. Davis SA, Sandoval LF, Gustafson CJ, Feldman SR, Cordoro KM. Treatment of preadolescent acne in the United States: an analysis of nationally representative data. Pediatr Dermatol. 2013 Nov-Dec; 30(6):689-94.
    View in: PubMed
    Score: 0.021
  188. Wong JW, Davis SA, Feldman SR, Koo JY. Trends in older adult psoriasis outpatient health care practices in the United States. J Drugs Dermatol. 2012 Aug; 11(8):957-62.
    View in: PubMed
    Score: 0.020
  189. McCall BP, Horwitz IB, Feldman SR, Balkrishnan R. Incidence rates, costs, severity, and work-related factors of occupational dermatitis: a workers' compensation analysis of Oregon, 1990-1997. Arch Dermatol. 2005 Jun; 141(6):713-8.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.